Pacific Biosciences of California Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
9
Price Target
$16.50
Consensus
Outperform
Upside
42.49%
Analysts
0
Stock Rating
9
Upside
42.49%
Analysts
0
Price Target
$16.50

Pacific Biosciences of California Stock Forecast and Price Target

Year-long price target forecasts from prominent analysts have recently been released for Pacific Biosciences of California, with an average price target of $16.50. This potential gain of 42.49 percent from the previous closing price in February, 2023 is calculated on a high forecast of $27.00 and a low estimate of $6.00. If you're thinking of investing in PACB stock, it might be good to look at its rivals too.

$16.50

42.49% Upside

Outperform
Outperform

Pacific Biosciences of California Fair Value Forecast for 2023 - 2025 - 2030

Pacific Biosciences of California's Price has grown In the last two years, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $11.45 – an increase of 100.00%. For the next nine years, experts predict that Pacific Biosciences of California's Fair Value will grow at a rate of 100.00%.

2022 Fair Value Forecast
$11.45
2023 Fair Value Forecast
$12.75
2024 Fair Value Forecast
$14.17
2025 Fair Value Forecast
$15.76
2026 Fair Value Forecast
$17.52
2027 Fair Value Forecast
$19.48
2028 Fair Value Forecast
$21.66
2029 Fair Value Forecast
$24.08
2030 Fair Value Forecast
$26.78
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
TMO Stock Forecast Thermo Fisher Scientific Inc Outperform 10
$587.76 $618.99 5.49%
ILMN Stock Forecast Illumina Inc Outperform 16
$214.26 $254.08 16.45%
QGEN Stock Forecast QIAGEN N.V. Outperform 15
$49.54 $0.00 11.02%
TXG Stock Forecast 10x Genomics Outperform 6
$47.84 $0.00 109.03%
300676 Stock Forecast BGI Genomics Outperform 17
¥56.82 ¥0.00 867.09%

Pacific Biosciences of California Revenue Forecast for 2023 - 2025 - 2030

Pacific Biosciences of California's Revenue has grown In the last two years, rising from $90.89M to $130.51M – a growth of 43.59%. According to the 0 analysts polled, in the next year, Pacific Biosciences of California's Revenue will fall by 21.30%, reaching $102.72M. By 2030, professionals believe that Pacific Biosciences of California's Revenue will have decreased by 18.66%, falling to $106.15M.

2022 Rev Forecast
$0.10B
2023 Rev Forecast
$0.10B
2024 Rev Forecast
$0.10B
2025 Rev Forecast
$0.11B
2026 Rev Forecast
$0.11B
2027 Rev Forecast
$0.11B
2028 Rev Forecast
$0.10B
2029 Rev Forecast
$0.11B
2030 Rev Forecast
$0.11B

Pacific Biosciences of California Dividend per Share Forecast for 2023 - 2025 - 2030

Pacific Biosciences of California Free Cash Flow Forecast for 2023 - 2025 - 2030

In the last two years, Pacific Biosciences of California's Free Cash Flow has grown, moving from $-81.15M to $-112.22M – an increase of 38.29%. In the following year, 0 experts forecast Pacific Biosciences of California's Free Cash Flow will decrease by 102.23%, to $2.51M. Looking ahead to nine years, experts forecast that Free Cash Flow will grow by 9358.70%.

2022 FCF Forecast
$0.00B
2023 FCF Forecast
$-39270880.27
2024 FCF Forecast
$0.53B
2025 FCF Forecast
$-7570074514.63
2026 FCF Forecast
$-10244581840.65
2027 FCF Forecast
$-9339643778.06
2028 FCF Forecast
$-12159904877.58
2029 FCF Forecast
$-10554392103.58
2030 FCF Forecast
$-10614552138.57

Pacific Biosciences of California Net Income Forecast for 2023 - 2025 - 2030

In the last two years, Pacific Biosciences of California's Net Income has grown by 115.40%, rising from $-84.13M to $-181.22M. According to 0 prominent analysts, Pacific Biosciences of California's Net Income will fall by 51.24% in the next year, reaching $-88.36M. By 2030, professionals believe that Pacific Biosciences of California's Net Income will decrease by 29.42%, reaching $-127.91M – a concerning trend for the company.

2022 NI Forecast
$-88362872.00
2023 NI Forecast
$-39807473.84
2024 NI Forecast
$-85359166.15
2025 NI Forecast
$-134784968.65
2026 NI Forecast
$-149139567.81
2027 NI Forecast
$-99600374.70
2028 NI Forecast
$-100745779.01
2029 NI Forecast
$-113836013.90
2030 NI Forecast
$-127913734.29

Pacific Biosciences of California EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Pacific Biosciences of California's EBITDA has seen an increase, rising from $-93.28M to $-170.89M. This represents a growth of 83.20%. According to 0 major analysts, Pacific Biosciences of California's EBITDA will fall by 30.31% in the next year, reaching $-119.09M. Professionals believe that By 2030, Pacific Biosciences of California's EBITDA will fall to $-128.36M– a 24.89% decrease from its current value.

2022 EBITDA Forecast
$-119087544.67
2023 EBITDA Forecast
$-118591346.56
2024 EBITDA Forecast
$-117694005.37
2025 EBITDA Forecast
$-135222565.91
2026 EBITDA Forecast
$-129912826.49
2027 EBITDA Forecast
$-126400849.74
2028 EBITDA Forecast
$-123834912.49
2029 EBITDA Forecast
$-127525192.89
2030 EBITDA Forecast
$-128358357.48

Pacific Biosciences of California EBIT Forecast for 2023 - 2025 - 2030

Pacific Biosciences of California's EBIT has seen growth In the last two years, going from $-100.55M to $-178.16M – a gain of 77.19% In the next year, 0 analysts estimate that Pacific Biosciences of California's EBIT will decrease by 29.11%, reaching $-126.29M. According to professional forecasts, in 2030, Pacific Biosciences of California's EBIT will decrease by 24.11%, reaching $-135.21M.

2022 EBIT Forecast
$-126291685.33
2023 EBIT Forecast
$-125660226.91
2024 EBIT Forecast
$-124319851.15
2025 EBIT Forecast
$-141993989.99
2026 EBIT Forecast
$-136849074.42
2027 EBIT Forecast
$-133377669.57
2028 EBIT Forecast
$-130670102.87
2029 EBIT Forecast
$-134341932.77
2030 EBIT Forecast
$-135210677.26

Pacific Biosciences of California EPS Price Prediction Forecast for 2023 - 2025 - 2030

Pacific Biosciences of California's EPS has grown In the last two years, rising from $-0.58 to $-0.93 – a growth of 60.34%. According to the 0 analysts polled, in the next year, Pacific Biosciences of California's EPS will fall by 24.37%, reaching $-0.70. By 2030, professionals believe that Pacific Biosciences of California's EPS will have decreased by 20.69%, falling to $-0.74.

2022 EPS Forecast
$-0.70
2023 EPS Forecast
$-0.69
2024 EPS Forecast
$-0.69
2025 EPS Forecast
$-0.77
2026 EPS Forecast
$-0.75
2027 EPS Forecast
$-0.73
2028 EPS Forecast
$-0.72
2029 EPS Forecast
$-0.73
2030 EPS Forecast
$-0.74